Status
Conditions
About
The etiology and pathogenesis of acute Achilles tendon ruptures are complex and not fully understood. It is well known that they are associated with pre-existing pathological alterations, similar to the changes observed in tendinopathy.
The present study investigates if bacteria and collagen metabolism play a role in the etiology of acute Achilles tendon rupture. During surgery, 20 patients will have taken two biopsies from the ruptured part of the tendon and two biopsies from the healthy tissue of the same tendon 2-4 cm proximal to the rupture, as a control.
Full description
Objectives
Background
Tendon ruptures are severe injuries that potentially lead to reduced function, reduced activity and sick leave. In younger, sports active individuals with strong tendons, an acute traumatic event is usually needed to trigger a rupture. With age the tendons are exposed to degenerative changes and can therefore rupture in everyday activities (spontaneously).
The etiology and pathogenesis of spontaneous tendon ruptures are complex and not fully understood. It is well known that they are associated with pre-existing pathological alterations, similar to the changes ob-served in tendinopathy. Recently, Dakin et al. found that ruptured Achilles tendons show evidence of chronic (non-resolving) inflammation. The condition might be a result of collagenolytic injury followed by failed tendon healing. Yet, other theories are still highly debated.
Many predisposing factors have been proposed to contribute to the pathological alterations of tendons. Studies found that factors such as increasing age, dominant arm, history of trauma and specific acromial anatomy are associated with rotator cuff tear. It is suggested that spontaneous tendon ruptures, primary Achilles tendon, are related to systemic and injectable steroids, fluoroquinolone use and some rheumatic diseases. Furthermore, studies have shown possible associations between genetic factors and tendon injury. The mentioned factors may influence the initiation and development of the patho-logical alterations that weaken the tendons. However, it is certain there are other mechanisms and predis-posing factors that need to be investigated.
Heinemeier et al. found that the bulk of the collagen matrix of healthy human Achilles tendon core is an essentially permanent structure that is laid down during height growth and has limited turnover in adults. The findings were based on the 14C bomb pulse method, and unpublished data from the same re-search group (using this method) indicates that an abnormally high rate of collagen turnover precedes symptoms of tendon overuse (tendinopathy)It is of great interest to investigate if increased collagen turno-ver predisposes to tendon rupture.
Recently, Rolf et al. demonstrated the presence of bacterial DNA in 25% of samples from ruptured Achilles tendons. Polymerase chain reaction (PCR) was used to identify the highly conserved bacterial 16S rDNA gene in the tendons. This finding open the question, if bacterial depositions play a role in the etiology of spontaneous tendon ruptures In order to prevent tendon ruptures it is essential to improve our understanding of the etiology. A better understanding may also lead to development of new therapeutic options.
In this cross-sectional study, we aim to investigate if bacteria potentially are contributing to the etiology of acute Achilles tendon rupture, Additionally, we also investigate if tendon ruptures are preceded by an in-creased collagen turnover.
Design of the study
The study is conducted as a cross-sectional study. Patients with acute rupture of the Achilles tendon are included The study aims to include 20 patients with acute Achilles tendon rupture.
The procedure for the patient:
At the day of inclusion, the patients will have taken a blood sample and ingest 150ml of deuterium oxide (D2O).
At the day of the surgery, the patient will meet 3 hours before the beginning of the surgery. A bolus of stable isotope (15N marked proline tracer) will be injected and afterwards continuous infused trough the antecubital vein. Blood samples are taken before infusion starts, 30min after, 60min af-ter, 120min after and when the biopsies are taken.
During the surgery, the patients will have taken:
Procedure for biopsies
All biopsies are taken by trained orthopedic surgeons. Every biopsy is taken during surgery in an operating theatre. Before the beginning of the surgery a sterile table is prepared containing three packs of sterile scalpels and forceps, and 8 containers for biopsies with the patient's social security (CPR), the type of analysis and a continues number individually describing each biopsy.
The 8 containers will hold:
Biopsies from ruptured tendons
Achilles tendon:
The biopsies are taken during open surgery. To prevent contamination of the biopsies the following proce-dure is followed:
Contamination tests
PCR and sequencing - Both a negative and a positive control is included in the test. Numbers of cycles in positive samples will also be included in the interpretation. Exclusively environmental bacterial species never been related to human disease are likely to be regarded as contaminants.
Blood culture - During surgery, blood a sample is send for culture to investigate if bacteria were presented in the blood.
Bacterial cultures - Bacterial culture tests are conducted on all patients. The investigated samples are taken with swaps from:
The swaps are collected in separate glass tubes and send to Department of Microbiology, Hvidovre Hospi-tal. The swaps are tested on multiple culture media for multiple species.
Blinding of the analysis
For each included patient, the 2 containers with biopsies for bacterial detection will get a randomized continues number. These numbers can, via a key document (paper form), reveal if the biopsy has been taken from the degenerative tissue or from the healthy tissue. The person responsible for the analyze of the bacterial DNA has no access to the key document.
Data registration during inclusion
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
20 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal